Markets
Companies See Fewer SEC Comments in Registration Process, Study Finds
|
Last year's IPOs may have had an easier time with Securities and Exchange Commission staff than in the previous two years.
Growth Capitalist (https://growthcapitalist.com/prominence/category-featured/page/24/)
This will allow you to designate a story to appear more prominently on category archive pages.
Last year's IPOs may have had an easier time with Securities and Exchange Commission staff than in the previous two years.
Investors led by Baupost Group are buying $165 million in convertible secured notes from Orexigen Therapeutics (OREX) to help fund the commercialization of Contrave as Orexigen buys the U.S. rights to the anti-obesity drug.
Business development companies might take a larger share of the growth company financing market, if legislation before Congress is approved.
Avant Diagnostics, Amarantus BioScience Holdings' diagnostics unit and Theranostics Health Inc. are merging so that the two makers of medical tests can take advantage of Theranostics's sales channel.